The week in industry: AstraZeneca and BenevolentAI collaborate to accelerate drug discovery
This week: The US FDA extends the use of BENLYSTA® to include children with lupus aged five and over, Abbvie (IL, USA) continues to gain worldwide approval of SKRIZI™ in Europe and Takeda (Tokyo, Japan) open new research facility in San Diego.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>